Ovarian cancer incidence and survival in Korea: 1993-2002

被引:29
作者
Chung, H. H.
Hwang, S. Y.
Jung, K. W.
Won, Y. J.
Shin, H. R.
Kim, J. W.
Lee, H. P.
机构
[1] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul 110744, South Korea
[2] Natl Canc Ctr, Korea Cent Canc Registry, Seoul, South Korea
关键词
incidence; Korea; ovary cancer; survival;
D O I
10.1111/j.1525-1438.2007.00824.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study examined incidence rates, histologic and stage distribution, and long-term survival rates of patients with ovarian cancer in Korea. A total of 11,404 patients diagnosed with ovarian cancer between 1993 and 2002 were reported to the Korea Central Cancer Registry and the Gynecologic Oncology Committee of Korean Society of Obstetrics and Gynecology. All rates were expressed per 100,000. The age-standardized incidence rates were 3.79 and 4.74 per 100,000 women in 1993 and 2002, respectively. The incidence rates of ovary cancer increased with age in Korea, and over half of the patients were in the stage IA (24.8%) and IIIC (26.8%) in this study. The 5-year relative survival rate was 59.6%. Relative survivals according to the stage of FIGO at 5 years were 91.1%, 75.2%, 46.4%, and 21.2% for stages I, II, III, and IV, respectively. The 5-year relative survivals of germ cell tumors and epithelial ovarian cancer were 89.0% and 58.3%, respectively. Surgical stage and histology were the most important prognostic factors of ovarian cancer. However, the 5-year survival rate of FIGO stage IC was significantly higher than that of stage IB.
引用
收藏
页码:595 / 600
页数:6
相关论文
共 22 条
  • [1] [Anonymous], 2006, J Natl Cancer Inst, V98, P511
  • [2] BAKER TR, 1994, CANCER, V74, P656, DOI 10.1002/1097-0142(19940715)74:2<656::AID-CNCR2820740218>3.0.CO
  • [3] 2-6
  • [4] Favorable prognostic value of tissue human kallikrein 11 (hk11) in patients with ovarian carcinoma
    Borgoño, CA
    Fracchioli, S
    Yousef, GM
    de la Longrais, IAR
    Luo, LY
    Soosaipillai, A
    Puopolo, M
    Grass, L
    Scorilas, A
    Diamandis, EP
    Katsaros, D
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (04) : 605 - 610
  • [5] Early detection and prognosis of ovarian cancer using serum YKL-40
    Dupont, J
    Tanwar, MK
    Thaler, HT
    Fleisher, M
    Kauff, N
    Hensley, ML
    Sabbatini, P
    Anderson, S
    Aghajanian, C
    Holland, EC
    Spriggs, DR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) : 3330 - 3339
  • [6] RELATIVE SURVIVAL AND THE ESTIMATION OF NET SURVIVAL - ELEMENTS FOR FURTHER DISCUSSION
    ESTEVE, J
    BENHAMOU, E
    CROASDALE, M
    RAYMOND, L
    [J]. STATISTICS IN MEDICINE, 1990, 9 (05) : 529 - 538
  • [7] Fiorica, 1996, Cancer Control, V3, P120
  • [8] SERUM HALF-LIFE OF CA-125 DURING EARLY CHEMOTHERAPY AS AN INDEPENDENT PROGNOSTIC VARIABLE FOR PATIENTS WITH ADVANCED EPITHELIAL OVARIAN-CANCER - RESULTS OF A MULTICENTRIC ITALIAN STUDY
    GADDUCCI, A
    ZOLA, P
    LANDONI, F
    MAGGINO, T
    SARTORI, E
    BERGAMINO, T
    CRISTOFANI, R
    [J]. GYNECOLOGIC ONCOLOGY, 1995, 58 (01) : 42 - 47
  • [9] Clear cell carcinoma of the ovary: A distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease
    Goff, BA
    delaCuesta, RS
    Muntz, HG
    Fleischhacker, D
    Ek, M
    Rice, LW
    Nikrui, N
    Tamimi, HK
    Cain, JM
    Greer, BE
    Fuller, AF
    [J]. GYNECOLOGIC ONCOLOGY, 1996, 60 (03) : 412 - 417
  • [10] Carcinoma of the ovary
    Heintz, APM
    Odicino, F
    Maisonneuve, P
    Beller, U
    Benedet, JL
    Creasman, WT
    Ngan, HYS
    Pecorelli, S
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2003, 83 : 135 - 166